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AIMS: Spontaneous ruptured hepatocellular adenoma (SRHA) is a rare life-threatening condition that may require surgical treat-
ment to control hemorrhaging and also stabilize the patient. We report a series of emergency surgeries performed at our institution 
for this condition. 
METHODS: We reviewed medical records and radiology files of 28 patients (from 1989 to 2006) with a proven diagnosis of he-
patocellular adenoma (HA). Three (10.7%) of 28 patients had spontaneous ruptured hepatocellular adenoma, two of which were 
associated with intrahepatic hemorrhage while one had intraperitoneal bleeding. Two patients were female and one was male. Both 
female patients had a background history of oral contraceptive use. Sudden abdominal pain associated with hemodynamic instability 
occurred in all patients who suffered from spontaneous ruptured hepatocellular adenoma. The mean age was 41.6 years old. The 
preoperative assessment included liver function tests, ultrasonography and computed tomography. 
RESULTS: The surgical approaches were as follows: right hemihepatectomy for controlling intraperitoneal bleeding, and right 
extended hepatectomy and non-anatomic resection of the liver for intrahepatic hemorrhage. There were no deaths, and the postop-
erative complications were bile leakage and wound infection (re-operation), as well as intraperitoneal abscess (re-operation) and 
pleural effusion.
CONCLUSION: Spontaneous ruptured hepatocellular adenoma may be treated by surgery for controlling hemorrhages and sta-
bilizing the patient, and the decision to operate depends upon both the patient’s condition and the expertise of the surgical team. 
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INTRODUCTION
Spontaneous ruptured hepatocellular adenoma (SRHA) is 
an unusual life-threatening condition. Although emergency 
surgery for ruptured hepatocellular adenoma (HA) of the 
liver is associated with high mortality and morbidity rates, 
it remains the treatment of choice.1,2 Emergency resection 
of ruptured HA has a mortality rate of between five and 
ten percent, whereas elective surgery has a mortality 
rate of less than one percent.3-5 A recent study showed 
that conservative management of ruptured HA may be a 
good alternative treatment, as none of the 12 patients in 
the study died.6 However, three of these patients required 
urgent laparotomy and gauze packing for life-threatening 
hemorrhage. Liver resection has been recommended for 
symptomatic or enlarging HA because of the associated 
risk of intraperitoneal or intrahepatic hemorrhage or even 
the development of hepatocellular carcinoma. Surgery 
eventually should be performed in any case of HA, provided 
it can be done without significant morbidity or mortality.3,7-10
Selective arterial embolization for ruptured HA may be a 
valuable alternative, although reports of this technique being 
employed are rare.11-16 The aim of this study was to describe 
the role of emergency surgery for SRHA.776
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METHODS
We reviewed the medical records and radiology files of 
28 patients with a proven diagnosis of HA at our institution 
from 1989 through 2006. Three (10.7%) of 28 patients had 
a SRHA, two of which were associated with intrahepatic 
hemorrhage and one with intraperitoneal bleeding. Two 
patients were female and one was male. The mean age was 
41.6 years old (38 to 46 years old). Sudden abdominal pain 
associated with hemodynamic instability occurred in all 
patients. The female patients had a background history of oral 
contraceptive use. Tumor markers including serum CA19-9, 
alpha-fetoprotein and carcino-embryonic antigen were normal 
in all patients. No chronic liver diseases were recorded in this 
series. Liver function tests, ultrasonography and computed 
tomography (CT) scans were performed in all three cases, and 
in one patient an MRI was also performed as shown in figures 
1 and 2. The criteria for diagnosing hepatic adenoma was the 
presence of a hypervascular heterogeneous mass on CT scan 
with intratumoral necrosis or hemorrhage and the presence 
of a capsule or pseudo-capsule (hypovascular area on CT) 
as described previously.17 (Table 1). Selective hepatic artery 
embolization was not available at the time of rupture, and 
due to hemodynamic instability all three patients underwent 
emergency surgery: on two occasions by the emergency room 
surgeons. and on one occasion by the hepatobiliary team. 
The liver surgical team advice was always available at the 
institution and all cases were discussed with the consultant 
physician. The anesthetic technique used was based on 
the principles of the acute hypovolemic patient, and the 
volume of blood loss as well as blood infusion was based on 
physiological parameters in the operative room; all solutions 
were warmed prior to infusion and administered via the rapid 
infusion system, commercially known as Level 1 system. A 
right subcostal incision was used extending to the left side (the 
classical “mercedes” incision), permitting full mobilization 
Figure 2 - T1-weighted fat-saturated gradient echo image of the liver 
shows the heterogeneous mass with high signal intensity (arrow), revealing 
a recent bleeding
Figure 1 - T2-weighted liver MR image shows a hyper-intense mass located 
in segment IV
Table 1 - Surgical management of spontaneous ruptured hepatocellular adenoma (SRHA)
n Sex/Gender Duration of 
contraceptive use 
Clinical findings Computed Tomogra-
phy
Treatment Tumor Size 
(cm)
Complications Length of 
hospital stay
1 M/46 - Intraperitoneal 
bleeding + HI
Heterogeneous 
image 
(hypoattenuating)
Right hemihepatectomy 
(S-V,VI,VII,VIII)
10 Bile leak 25 days
2 F/38 3 years Intrahepatic 
bleeding + HI
Heterogeneous 
image 
(hyperattenuating) 
+ necrosis/
hemorrhage
Non-anatomic hepatic 
resection 
(S-IVb,V,VI,VII,VIII)
12 Subphrenic 
abscess
43 days
3 F/ 41 5 years Intrahepatic 
bleeding + HI
Heterogeneous 
image 
(hyperattenuating) + 
necrosis/hemorrhage
Extended right 
hepatectomy 
(S-IVa,IVb,V,VI,VII,VIII)
13 Pleural effusion 28 days
M- male; F- female; HI- hemodynamic instability; S-segments.777
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of the liver considering that in all cases the teams had a 
preoperative diagnosis of liver injury. Once laparotomy was 
performed, hemostasis or damage control was accomplished 
using absorptive gauzes and two opposing pressure vectors 
to compress the ruptured tissue between them. Surgical 
procedures included intraoperative ultrasonography to assess 
the size and location of the tumor as well as the relationship 
between the lesion and vascular system. The cases were 
handled using hepatic surgical techniques including vascular 
control of the portal pedicle and, in one case, control of the 
inferior vena cava close to the confluence of the hepatic vein. 
None of the cases required temporary hepatic inflow occlusion 
(Pringle maneuver) or clamping of the IVC. Dissection 
throughout the liver parenchyma was performed using the 
Kelly clamp crushing technique, an argon beam generator, 
CUSA®, and ligation of identified vessels with Prolene 
sutures.
RESULTS
Clinical and biochemical findings of SRHA are shown 
in Table 2. All three patients with SRHA had sudden acute 
right upper quadrant (RUQ) pain. Biochemical examination 
showed slightly elevated levels of y-glutamyl transpeptidase, 
bilirubin and alkaline phosphatase. Other liver function 
tests were within normal limits. Oral contraceptives were 
taken by two patients. A CT scan was performed on all three 
patients. Intrahepatic heterogeneous (hyperattenuating) 
images were seem in all three patients, corresponding with 
intrahepatic bleeding. In one of those patients hemorrhagic 
ascites was also detected in the CT scan. Intrahepatic and 
intraabdominal bleeding occurred in two patients and one 
patient, respectively. The mean tumor diameter was 11.6 
(ranging from 10 to13) centimeters. The standard surgical 
procedure was anatomic-based hepatic resection (Figure 
3) in two patients and a non-anatomical segmental hepatic 
resection in a third. Complications of the surgical procedure 
were observed in patients with SRHA. The patient submitted 
to right hemihepatectomy for intraperitoneal hemorrhage 
had a bile leak and underwent re-operation on the 18th 
postoperative day. The bile leak closed six weeks later. The 
patient submitted to a non-anatomic resection of the liver 
due to intrahepatic bleeding developed a right subphrenic 
abscess on the 13th postoperative day requiring a surgical 
intervention. The patient submitted to an extended right 
hepatectomy (also due to intrahepatic bleeding) developed 
a right pleural effusion immediately after the surgery 
associated with moderate restrictive respiratory insufficiency 
requiring therapeutic thoracentesis. Lengths of hospital stay 
were 25, 43 and 28 days, respectively.
There were no deaths in this series. The mean follow-up 
was 22 months (ranging from 8 to 62 months). All patients 
are alive with no evidence of tumor recurrence to date.
DISCUSSION
HA is a rare benign hepatic neoplasm that is of interest 
for at least three reasons: (1) it may be difficult to distinguish 
from other benign or malignant hepatic tumors; (2) it may 
undergo malignant transformation and (3) it has a marked 
tendency to hemorrhage.18-21 HA is notoriously difficult 
to diagnose pre-operatively by clinical, radiographic, or 
histological means. The diagnostic challenge involves 
differentiating HA from focal nodular hyperplasia or 
hepatocellular carcinoma. Clinically, abdominal pain is 
a frequent presenting symptom3 but it is not specific for 
HA versus focal nodular hyperplasia or hepatocellular 
Table 2 - Clinical and biochemical findings in patients (n=3) 
with spontaneous rupture hepatocellular adenoma (SRHA)
Feature SRHA (3)
Mean age (years) 41.6 (38-46) 
Acute RUQ* abdominal pain 03
Oral contraceptive use 02
Palpable mass 03
Elevated alkaline phosphatase 03
Elevated GGT** 03
Elevated bilirubin 03
Intrahepatic bleeding 02
Intraabdominal bleeding 01
*RUQ: right upper quadrant
**GGT: gama-glutamyl transpeptidase
Figure 3 - Spontaneous rupture hepatocellular adenoma showing areas of 
hemorrhage and liver parenchyma damage778
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carcinoma.22 This report describes three patients with SRHA 
who had sudden right upper quadrant abdominal pain 
corresponding to the liver area associated with hemodynamic 
instability. Laboratory assessment of a SRHA may show 
liver enzyme changes (elevated alkaline phosphatase, GGT 
and bilirubin) in association with acute expansion of the 
neoplasm from hemorrhagic necrosis or even intrahepatic 
hemorrhage. CT permits an accurate diagnosis in typical 
cases of HA showing hyperdense mass with heterogeneous 
enhancement,23,24 however typical features on CT were 
found in only 75% of the cases.23 We found SRHA to be a 
heterogeneous mass in all three patients, however the patient 
with an intraperitoneal hemorrhage had a hypoattenuating 
image while the two patients with intrahepatic bleeding had 
hyperattenuating images, corresponding to liver necrosis 
on the CT examination. Hussain et al.25 presented findings 
of HA on ultrasonography, CT and MRI, and correlating 
these findings with the pathological analysis. It was noted 
that in the case of monophasic CT or when arterial phase 
is performed incorrectly, HA can easily be misdiagnosed, 
exposing patients to unnecessary delays in diagnosis and 
proper treatment. It was noted that today, MRI is a state-
of-the-art imaging modality due to its ability to provide a 
more comprehensive and accurate work-up of focal and 
diffuse liver disease. This is based on the unique properties 
of MR imaging; it possess a combination of high intrinsic 
soft tissue contrast of the liver and liver lesions, various 
distinctly different tissue characteristics for imaging and 
a high sensitivity for the presence or absence of contrast-
uptake and enhancement patterns when using either non-
specific or liver-specific contrast media. Some patients 
with HA are discovered accidentally on routine physical 
examination or even during exploratory laparotomy for 
another indication. These patients usually have totally 
asymptomatic liver masses and no laboratory evidence to 
suggest liver disease. On the other hand, fifty to sixty percent 
of patients with HA have intratumoral or intraperitoneal 
hemorrhages.25,26 These patients are first seen with a sudden 
life-threatening intraabdominal hemorrhage. Substantial 
mortality has been associated with delays in diagnosis of 
this condition; mortality arises from hemorrhagic shock, 
rapidly developing coagulopathies, and postoperative 
complications. Successfully treated patients had liver 
segmentectomies performed as an emergency procedure. 
It is apparent that early diagnosis and operation are critical 
in this group. Three patients in our series had ruptures; two 
of them intrahepatically and one intraabdominally. The 
former were treated with non-anatomic hepatic resection 
associated with right hepatectomy (Figure 3) and the latter 
with right extended hepatectomy. The risk of HA bleeding 
increases with increased duration of oral contraceptive 
use and is related to the hormonal potency of the oral 
contraceptives used regardless of the duration of use.27 
The two female patients with intrahepatic bleeding were 
using hormonal contraceptives for at least three years. 
Whether this use was the cause of their SRHA or not is a 
matter of speculation because we believe that many factors 
appear to be interrelated including: (1) the woman’s age, 
(2) the size of the tumor and (3) the potency of the oral 
contraceptive used. Size of the hepatocellular adenoma is 
an established independent risk factor for malignancy.11,13,28 
Surgical resection has been recommended for adenomas 
with an initial diameter of 5 cm or more in symptomatic 
patients, even during pregnancy.6,29 The resection of 
large adenomas has also been recommended because 
the risk of hemorrhaging is relatively high. For smaller 
and asymptomatic adenomas, an expectant approach 
is advocated.30,31 The main surgical procedure for HA 
should be local or hepatic segmental resection in order to 
preserve the normal hepatic parenchyma since the tumor 
is benign. In the emergency setting, if the surgeon on call 
at the emergency room have the appropriate surgical skills 
to handle liver lesions, the full procedure can be safely 
performed by them; otherwise, the lesion must be handled 
as in hepatic trauma, with packing and damage control, and 
after the initial approach the HPB team must be consulted 
for a definite surgical approach. In the unlikely event of 
SRHA we recommend an anatomical-based resection of the 
liver or even non-anatomical resection depending upon the 
complexity of the intrahepatic or extrahepatic hemorrhage. 
SRHA is a rare life-threatening condition. In this series 
there were HAs larger than 10 cm. Today, it is well 
known that hepatocellular adenomas are only vascularized 
arterially. This makes embolization safe and successful 
for stopping hemorrhages in acute settings. In our cases, 
the interventional radiology group was not yet available to 
perform the procedure and instead surgery was indicated. 
Hurmann et al.16 demonstrated that the ability of selective 
arterial embolization to induce necrosis of the tumor may 
indicate a role for this procedure in the management of either 
bleeding or non-bleeding adenomas with good results and 
lower complication rates when compared to surgery.
 In conclusion, SRHA may necessitate emergency 
surgery for controlling hemorrhage and stabilizing the 
patient, and the decision to operate depends both upon the 
patient’s condition and the expertise of the surgical team. 779
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